Study Comparing Two Different Tablet Formulations Of Bosutinib

Completed · Phase 1

Conditions studied: Healthy

In brief

This study is comparing 2 formulations of bosutinib in healthy subjects.

Key facts

Study ID

NCT00934674

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

30

Starts

2009-07-01

Expected to finish

2009-08-01

Last updated by the study team

2009-09-02

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men or women of non-childbearing potential, age 18 to 50 years.

You may not qualify if…

• Any significant cardiovascular, renal, hepatic, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.

Where it is running

• Study site — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.